Mechanical Circulatory Support
- 872 Downloads
In other chapters, there are detailed discussions of acute decompensated heart failure (Chap. 19) and shock (Chap. 21). Cardiogenic shock (CS) represents a state in which cardiac dysfunction is either wholly or partially responsible for an inadequate level of cardiac output to support end-organ function. CS is an especially dangerous state, with in-hospital mortality as high as 27–51% (van Diepen et al., Circulation. 136:e232–68, 2017). Therefore, interventions that promptly reverse the pathophysiologic process are critical. While CS can result from a variety of etiologies – acute myocardial infarction (AMI), acute valvular regurgitation, decompensated heart failure, ventricular tachycardic storm, or myocarditis, to name just a few – once the insult triggers primary dysfunction, the nature of CS is a downward spiral of consequences ultimately resulting in multi-organ failure and death. Even if myocardial ischemia is not the primary cause of cardiac dysfunction, a drop in cardiac output and coronary perfusion pressure during CS nonetheless leads to ischemia and further systolic and diastolic dysfunction, both of which precipitate a feedback loop of progressive dysfunction. This chapter focuses on the use of mechanical circulatory support (MCS) to intervene in the early stages of this cycle.
- 5.Parissis H, Graham V, Lampridis S, Lau M, Hooks G, Mhandu PC. IABP: history-evolution-pathophysiology-indications: what we need to know. J Cardiothorac Surg. 2016;11. https://doi.org/10.1186/s13019-016-0513-0.
- 13.Seyfarth M, Sibbing D, Bauer I, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52(19):1584–8. https://doi.org/10.1016/j.jacc.2008.05.065.CrossRefPubMedGoogle Scholar
- 14.Engström AE, Cocchieri R, Driessen AH, et al. The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: the Academic Medical Center intensive care unit experience. Crit Care Med. 2011;39(9):2072–9. https://doi.org/10.1097/CCM.0b013e31821e89b5.CrossRefPubMedGoogle Scholar
- 18.Lima B, Kale P, Gonzalez-Stawinski GV, Kuiper JJ, Carey S, Hall SA. Effectiveness and safety of the Impella 5.0 as a bridge to cardiac transplantation or durable left ventricular assist device. Am J Cardiol. 2016;117(10):1622–8. https://doi.org/10.1016/j.amjcard.2016.02.038.CrossRefPubMedGoogle Scholar
- 20.Burkhoff D, Cohen H, Brunckhorst C, O’Neill WW. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006;152(3):469.e1–8. https://doi.org/10.1016/j.ahj.2006.05.031.CrossRefGoogle Scholar
- 21.Thiele H, Sick P, Boudriot E, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;26(13):1276–83. https://doi.org/10.1093/eurheartj/ehi161.CrossRefPubMedGoogle Scholar
- 23.Rao P, Khalpey Z, Smith R, Burkhoff D, Kociol RD. Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest. Circ Heart Fail. 2018;11(9):e004905. https://doi.org/10.1161/CIRCHEARTFAILURE.118.004905.CrossRefPubMedGoogle Scholar
- 24.Patel S, Lipinski J, Al-Kindi S, et al. Simultaneous venoarterial extracorporeal membrane oxygenation and percutaneous left ventricular decompression therapy with Impella is associated with improved outcomes in refractory cardiogenic shock. ASAIO J. 2019;65(1):21–8. https://doi.org/10.1097/MAT.0000000000000767.CrossRefPubMedGoogle Scholar
- 33.Kuchibhotla S, Esposito ML, Breton C, et al. Acute biventricular mechanical circulatory support for cardiogenic shock. J Am Heart Assoc. 2017;6(10). https://doi.org/10.1161/JAHA.117.006670.